![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 10, 4670-4675, 04, 1987
LC Pan and PA Price
The specific binding of radiolabeled 1,25-dihydroxyvitamin D3 (1,25(OH)2D3)
to intact rat osteosarcoma (ROS 17/2) cells was followed for 24 h. In the
presence of 0.5-1.5 nM 1,25(OH)2D3, hormone binding increased over a period
of 12 h, from 1.1 X 10(4) to 1.3 X 10(5) receptors/cell. The elevated level
of hormone binding persisted through 24 h provided that the initial
concentration of hormone was maintained. The concentration dependence of
this increase in receptor level was centered between 10 and 30 pM
1,25(OH)2D3, and the binding at 12 h exhibited the metabolite specificity
expected for a 1,25(OH)2D3 receptor. The t 1/2 values for the disappearance
of unoccupied and occupied receptors were roughly the same, approximately
2.7 h; therefore, the increase in hormone binding was not due to receptor
stabilization. In comparison, hormone-receptor complexes appeared to
dissociate with a t 1/2 of 1 h. alpha-Amanitin treatment reduced the
magnitude of receptor accumulation by 50-60%, indicating that mRNA
synthesis was required to achieve the maximal response. Ligand- dependent
regulation of cellular receptor levels provides a mechanism for amplifying
the primary hormonal signal and is predicted to influence the kinetics,
magnitude, and dose dependence of cellular responses.
Ligand-dependent regulation of the 1,25-dihydroxyvitamin D3 receptor in rat osteosarcoma cells [published erratum appears in J Biol Chem 1987 Jul 25;262(21):10413]
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
K. D. Healy, J. B. Zella, J. M. Prahl, and H. F. DeLuca Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium PNAS, August 19, 2003; 100(17): 9733 - 9737. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. FINCH, A. S. DUSSO, T. PAVLOPOULOS, and E. A. SLATOPOLSKY Relative Potencies of 1,25-(OH)2D3 and 19-Nor-1,25-(OH)2D2 on Inducing Differentiation and Markers of Bone Formation in MG-63 Cells J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1468 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Sims, C. P. White, K. L. Sunn, G. P. Thomas, M. L. Drummond, N. A. Morrison, J. A. Eisman, and E. M. Gardiner Human and Murine Osteocalcin Gene Expression: Conserved Tissue Restricted Expression and Divergent Responses to 1,25-Dihydroxyvitamin D3 in Vivo Mol. Endocrinol., October 1, 1997; 11(11): 1695 - 1708. [Abstract] [Full Text] |
||||
![]() |
K.-i. Miyamoto, R. A. Kesterson, H. Yamamoto, Y. Taketani, E. Nishiwaki, S. Tatsumi, Y. Inoue, K. Morita, E. Takeda, and J. W. Pike Structural Organization of the Human Vitamin D Receptor Chromosomal Gene and Its Promoter Mol. Endocrinol., July 1, 1997; 11(8): 1165 - 1179. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |